ホーム › 非小細胞肺癌 › ニューヨーク › Queens
Queens、NYにおける非小細胞肺癌の臨床試験
Queensとその周辺地域（約30マイル以内）の拠点で、非小細胞肺癌に関する49件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
被験者募集中第2相
- Clinical Research Alliance - Westbury /ID# 270455, Westbury · 14マイル先
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
被験者募集中第3相
- Northwell Health/Center for Advanced Medicine, Lake Success · 9マイル先
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
被験者募集中第1相
- START New York Long Island LLC, Lake Success · 9マイル先
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
被験者募集中第2相
- Memorial Sloan Kettering Nassau, Uniondale · 13マイル先
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
被験者募集中第2/3相
- NYU Langone Hospital Long Island, Mineola · 11マイル先
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
被験者募集中第3相
- New York Cancer & Blood Specialists - New Hyde Park, New Hyde Park · 9マイル先
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
被験者募集中第3相
- Optum Medical Care, PC, Westbury · 14マイル先
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
被験者募集中第3相
- Local Institution - 0224, Laurelton · 5マイル先
- Optum Medical Care, PC, Westbury · 14マイル先
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
被験者募集中第3相
- Optum Medical Care, PC, Westbury · 14マイル先
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
被験者募集中第3相
- Research Site, Fresh Meadows · 4マイル先
- Research Site, Westbury · 14マイル先
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
被験者募集中第2相
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11マイル先
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
被験者募集中第2/3相
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11マイル先
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
被験者募集中第1/2相
- START New York, Lake Success · 9マイル先
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
被験者募集中第3相
- Research Site, Westbury · 14マイル先
A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer
被験者募集中第1相
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13マイル先
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
被験者募集中第2相
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13マイル先
Using Urine Samples to Identify Lung Cancer
被験者募集中観察研究健康なボランティア歓迎
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13マイル先
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
被験者募集中第2相
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13マイル先
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
被験者募集中第1相
- Site 107 - START New York - Long Island, Lake Success · 9マイル先
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation
被験者募集中第1/2相
- NYU Langone Hospital - Long Island, Mineola · 11マイル先
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
被験者募集中第3相
- Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success · 9マイル先
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11マイル先
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
被験者募集中第3相
- Clinical Research Alliance, Westbury · 14マイル先
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
被験者募集中第1相
- NYU Langone Health - Long Island, Mineola · 11マイル先
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
被験者募集中第1相
- START NY Long Island, Lake Success · 9マイル先
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
被験者募集中第1/2相
- START New York Long Island, New Hyde Park · 9マイル先
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
被験者募集中第1相
- Perlmutter Cancer Center at NYU Langone Hospital Long Island, Mineola · 11マイル先
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
被験者募集中
- Memorial Sloan Kettering Nassau (Limited protocol activities), Rockville Centre · 10マイル先
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
被験者募集中第3相
- Northwell Health/R.J. Zuckerberg Cancer Center, Lake Success · 9マイル先
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
被験者募集中第3相
- NYU Langone Hospital - Long Island, Mineola · 11マイル先
- Memorial Sloan Kettering Nassau, Uniondale · 13マイル先
A Study of MGC026 in Participants With Advanced Solid Tumors
被験者募集中第1相
- START-New York Long Island, Lake Success · 9マイル先
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
被験者募集中第2相
- Memorial Sloan Kettering Nassau, Uniondale · 13マイル先
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
被験者募集中第1/2相
- Northwell Health, Lake Success · 9マイル先
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
被験者募集中第3相
- Queens Cancer Center, Rego Park · 3マイル先
- Northwell Health/Center for Advanced Medicine, Lake Success · 9マイル先
A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer
被験者募集中第1/2相
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13マイル先
Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung Cancer
被験者募集中観察研究
- Memorial Sloan Kettering Nassau (Consent Only), Uniondale · 13マイル先
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
被験者募集中第1相
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New Hyde Park · 9マイル先
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Babylon · 27マイル先
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
被験者募集中第1/2相
- Clinical Research Alliance, Westbury · 14マイル先
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
被験者募集中第3相
- New York Cancer & Blood Specialists (NYCBS), New Hyde Park · 9マイル先
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
被験者募集中第1相
- START New York Long Island, LLC, Lake Success · 9マイル先
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
被験者募集中第1相
- START New York Long Island, LLC, Lake Success · 9マイル先
A Study of Ivonescimab in People With Non-Small Cell Lung Cancer
被験者募集中第1/2相
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13マイル先
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)
被験者募集中第2相
- Memorial Sloan Kettering Nassau (All protocol activities), Rockville Centre · 10マイル先
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
被験者募集中第2相
- Memorial Sloan Kettering Nassau, Uniondale · 13マイル先
A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer
被験者募集中第1/2相
- Memorial Sloan Kettering Nassau (All Protocol Activities), Rockville Centre · 10マイル先
Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer
被験者募集中第2相
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13マイル先
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
被験者募集中観察研究
- Queens Hospital Center, Jamaica · 2マイル先
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
被験者募集中第2相
- Memorial Sloan Kettering Nassau, Uniondale · 13マイル先
A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer
被験者募集中第2相
- Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · 10マイル先
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Hempstead · 12マイル先
他の都市における非小細胞肺癌の試験
- Houston, TX145件の研究
- New York City, NY121件の研究
- Arlington, VA104件の研究
- Nashville, TN97件の研究
- Boston, MA90件の研究
- Los Angeles, CA87件の研究
- St. Louis, MO73件の研究
- Chicago, IL61件の研究
- Baltimore, MD60件の研究
- San Antonio, TX59件の研究
- Columbus, OH57件の研究
- Washington, DC55件の研究
Queensにおける他の研究
- 乳がん64件の研究
- 大腸癌31件の研究
- 転移性癌28件の研究
- 卵巣がん28件の研究
- 前立腺がん27件の研究
- がん（全種類）26件の研究
- 子宮内膜がん25件の研究
- 肺がん22件の研究
- 急性骨髄性白血病21件の研究
- 多発性骨髄腫20件の研究
- 膵臓がん20件の研究
- 頭頸部扁平上皮癌20件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。